This study looks at how well the treatment Dato-DXd works, with or without another medicine called durvalumab, compared to standard chemotherapy options in patients with triple-negative breast cancer. The main goal is to see if Dato-DXd helps patients live longer without their cancer getting worse. This trial is open to adults with a specific type of breast cancer that has come back or spread and is not able to be treated with surgery.
The trial's ID number is NCT06103864. It is a Phase 3 study, which means it is looking at how well the treatment works and how safe it is. The study plans to include about 625 participants and is regulated by the FDA.
Who can join
This study is for adults aged 18 and older, both men and women, who have been diagnosed with triple-negative breast cancer that has returned or spread. Participants should not have had prior chemotherapy for this type of breast cancer and must meet other health requirements. The trial team will confirm if someone is eligible to join.
Condition
Breast Cancer
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be placed into different groups by chance. One group will receive Dato-DXd along with durvalumab, another group will receive a choice of standard chemotherapy with pembrolizumab, and the last group will receive Dato-DXd alone. Everyone will receive treatment through intravenous (IV) infusions.
Where
This trial is enrolling at 64 locations. Recruiting sites are listed first.
Director of the Breast Cancer Center at NYU Langone’s Perlmutter Cancer Center. Treats breast cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Inaugural Jeffrey F. Moley Professor of Endocrine and Oncologic Surgery, WashU. Treats breast cancer. A surgeon is the doctor who removes cancer with an operation (adults). Recognized at state, national or international level.
Microsurgical breast reconstruction specialist, MSK. Treats breast cancer and mouth cancer. Offers microsurgical breast reconstruction, head and neck reconstruction and abdominal wall reconstruction.